Pancreatic Cancer Research

ResearcherZhejiang Chinese Medical UniversityNo recent work listed

Dian-Lei Liu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5072532846. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2012: 3 papers · 2013: none · 2014: 2 papers · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 6

  1. Oridonin enhances the anti-tumor activity of gemcitabine towards pancreatic cancer by stimulating Bax- and Smac-dependent apoptosis. Co-author DOI 10.21037/tcr-19-3000↗
  2. Enhancement of the effects of gemcitabine against pancreatic cancer by oridonin via the mitochondrial caspase-dependent signaling pathway. Co-author DOI 10.3892/mmr.2014.2584↗
  3. Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK. First author DOI 10.3892/or.2013.2888↗
  4. Antitumor activity of emodin against pancreatic cancer depends on its dual role: promotion of apoptosis and suppression of angiogenesis. Last author DOI 10.1371/journal.pone.0042146↗
  5. Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro. Co-author DOI 10.3892/ijo.2011.1285↗
  6. Enhanced antitumor efficacy of gemcitabine by evodiamine on pancreatic cancer via regulating PI3K/Akt pathway. Co-author DOI 10.7150/ijbs.8.1↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Heqi Bu · 4 shared papers, 2012–2020 · strength 0.27
  2. Bo-Ning Cheng · 1 shared paper, 2020 · strength 0.15
  3. Weitian Wei · 3 shared papers, 2012–2014 · strength 0.11
  4. Hai Huang · 2 shared papers, 2014 · strength 0.10
  5. Hongfei Tong · 3 shared papers, 2012 · strength 0.09
  6. Hongchun Guo · 3 shared papers, 2012 · strength 0.09
  7. Zhaohong Wang · 2 shared papers, 2012 · strength 0.06
  8. Sheng‐Zhang Lin · 2 shared papers, 2012 · strength 0.06
  9. Junhui Cui · 1 shared paper, 2014 · strength 0.05
  10. Shengzhang Lin · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.